Connect Biopharma Holdings Ltd American Stock Forecast
Stronger technical forecast for Connect Biopharma Holdings Ltd American stock price after Thursday trading.
(Updated on Apr 25, 2024)
The Connect Biopharma Holdings Ltd American stock price fell by -0.730% on the last day (Thursday, 25th Apr 2024) from $1.37 to $1.36. During the last trading day the stock fluctuated 5.34% from a day low at $1.31 to a day high of $1.38. The price has fallen in 7 of the last 10 days and is down by -29.17% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -7 thousand shares and in total, 34 thousand shares were bought and sold for approximately $46.12 thousand.
Given the current short-term trend, the stock is expected to rise 37.94% during the next 3 months and, with a 90% probability hold a price between $1.88 and $3.30 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CNTB Signals & Forecast
There are few to no technical positive signals at the moment. The Connect Biopharma Holdings Ltd American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.44 and $1.53. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -38.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock
Connect Biopharma Holdings Ltd American finds support from accumulated volume at $1.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0700 between high and low, or 5.34%. For the last week the stock has had daily average volatility of 10.69%.
Connect Biopharma Holdings Ltd American is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CNTB) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $1.35, and during the day (based on 14 day Average True Range), to move between $1.14 and $1.58, which gives a possible trading interval of +/-$0.216 (+/-15.88%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 31.76% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.33 (2.21%) than the resistance at $1.40 (2.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?
The Connect Biopharma Holdings Ltd American stock holds several negative signals and despite the positive trend, we believe Connect Biopharma Holdings Ltd American will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.800 Sell Candidate Upgraded
Predicted Opening Price for Connect Biopharma Holdings Limited American Depositary Shares of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $1.35 ( 0.735%) | $1.36 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CNTB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.42 | 4.41 % | |
| R2 | 1.39 | 2.45 % | ||
| R1 | 1.38 | 1.23 % | ||
| Current price: | 1.36 | |||
| Support | S1 | 1.32 | -2.70 % | |
| S2 | 1.31 | -3.92 % | ||
| S3 | 1.28 | -5.88 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.67 | 22.79 % | |
| R2 | 1.61 | 18.38 % | ||
| R1 | 1.40 | 2.94 % | ||
| Current price | 1.36 | |||
| Support | S1 | 1.33 | -2.21% | |
| S2 | 1.24 | -9.19% | ||
| S3 | 1.12 | -17.65% |
FAQ
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.
